Laboratory News and Research

RSS

Bridging science and family story to understand schizophrenia origins

Twin studies have placed the heritability of schizophrenia at roughly eighty percent for decades. Concordance between identical twins, who share the entire genome, does not reach fifty percent. Both figures are well established, and they do not fit together comfortably.

2 Sep 2026

Hidden sperm structures may offer new clues to male fertility

Researchers at VIB, VUB, and the Medical Research Council Laboratory of Molecular Biology (UK) have discovered a hidden feature of human sperm cells.

2 Sep 2026

Europe has a new mosquito problem, but it may not be the one you think

A scoping review of 91 studies, combined with a workshop involving 41 experts from six European countries, mapped the spread, biology, surveillance challenges, and potential disease relevance of the invasive mosquito Aedes koreicus. The researchers identified major gaps in species identification, vector competence, ecology, genetics, and long-term surveillance that must be addressed as the cold-tolerant mosquito expands across Europe.

2 Sep 2026

Smartwatches may overestimate calories burned during exercise

Smartwatches can significantly overestimate how many calories people burn during exercise, and their calorie estimates become less accurate as body fat increases, according to a new Florida International University study.

1 Sep 2026

New brain atlas reveals insights into Huntington's, addiction, and other disorders

A region of the brain called the striatum is critical for many cognitive and motor functions, including decision-making, control of movement, habit formation, and processing of reward.

1 Sep 2026

Antifungal medication may reduce inflammatory bowel disease symptoms

A commonly used systemic antifungal medication may help reduce symptoms in a subset of patients with inflammatory bowel disease (IBD) by restoring a healthier gut microbiome, according to a preliminary study by Weill Cornell Medicine investigators.

1 Sep 2026

AI platform uncovers new molecular targets for Alzheimer's disease

Groundbreaking study published in Alzheimer's & Dementia reveals the crucial links between the NAD⁺-mitophagy axis and neurodegeneration.

1 Sep 2026

New method based on human blood simplifies mRNA drug development

mRNA-based drugs are emerging as the drug of the future for a wide range of diseases, but they are difficult and time-consuming to develop.

1 Sep 2026

Multiple sclerosis treatment approach developed at Mainz University moves toward clinical application

A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step toward clinical application.

1 Sep 2026

Adolescent binge drinking causes lasting changes in brain function

New research from the Marshall University Joan C. Edwards School of Medicine provides insight into how binge alcohol exposure during adolescence may cause lasting changes in brain function that persist into adulthood, potentially identifying a new target for future treatment approaches.

1 Sep 2026

How far your eyes move may change what you see

Researchers found that the distance the eye travels during a rapid gaze shift changes post-saccadic visual sensitivity by altering the spatial-frequency information carried by retinal luminance transients. Larger saccades preferentially enhanced lower-frequency, coarser visual information, while very small saccades could increase the relative visibility of finer, higher-frequency information.

31 Aug 2026

Precision psychiatry aims to match schizophrenia patients with tailored medicines

Imagine watching a son or daughter begin college during a formative time in life, only to have schizophrenia suddenly alter their reality.

31 Aug 2026

Catheter-directed thrombolysis improves short-term outcomes in pulmonary embolism patients

In patients with intermediate−high risk pulmonary embolism, catheter-directed thrombolysis improved short-term clinical outcomes compared with standard anticoagulation therapy alone, according to results presented in a Hot Line session today at ESC Congress 2026.

31 Aug 2026

New dual-drug strategy blocks triple-negative breast cancer growth

Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease to return and become resistant to treatment.

31 Aug 2026